Delivery of siRNA using novel conjugates for cancer therapy.
Short interfering RNAs (siRNAs) trigger RNA interference (RNAi). This offers great potential as a novel therapeutic treatment based on its highly specific silencing of the encoded protein. A major barrier to the advancement of siRNA therapies is the development of delivery carriers capable of effect...
Saved in:
Main Author: | Guo, Venetia Yixin. |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Final Year Project |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/40472 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Magnetic nanoparticle formulations for DNA and siRNA delivery
by: Olga Mykhaylyk, et al.
Published: (2018) -
Carbohydrate-based nanocarriers for targeted drug and siRNA delivery
by: Tan, Yu Jia
Published: (2016) -
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
by: Mirzaei, Sepideh, et al.
Published: (2023) -
Self-assembling β-glucan nanomedicine for the delivery of siRNA
by: Lee, Kyungwoo, et al.
Published: (2020) -
Fabrication of Methacrylated-Chitosan based nanolipogel for siRNA delivery
by: Lu, Yichen
Published: (2020)